Earth Alive Completes Sale Transaction: A New Dawn for the Microbial Technologies Industry

Earth Alive Clean Technologies Inc. (TSXV: EAC) has announced the completion of a significant sale transaction, marking a new chapter in the company's history and positioning it for future growth in the microbial technologies industry. The transaction, approved by the Superior Court of Québec (Commercial Division), involves the sale of all equity interest in the Company, including all issued and outstanding common shares, to 9530-8086 Québec Inc. (the "Purchaser"). The Purchaser is a group of investors, including Mr. Erik Bomans, a director of the Company, and Mr. Nikolaos Sofronis, a director and the chief executive officer of the Company.

Following the closing of the Transaction, the Purchaser now holds all of the issued and outstanding shares in the capital of the Company. The vast majority of the Company's indebtedness was assumed under the Transaction, and all of the Company's Employees will continue to be employed by the Company. The Company's petitioner status in the bankruptcy proceedings is expected to cease, and the ResidualCos, newly-incorporated special-purpose vehicles, will be liquidated and wound-up by way of bankruptcy proceedings.

The Autorité des marchés financiers (Québec) had issued a partial revocation order in respect of the failure-to-file cease trade order issued by the AMF on September 4, 2024, solely for the purpose of completing the Transaction with the Purchaser. Following the completion of the Transaction, the Company now intends to apply for a cease to be a reporting issuer order for ceasing to be a reporting issuer in all jurisdictions of Canada.

The Transaction is an arms-length transaction, and no intermediary fees are payable in connection with the Transaction. The Transaction is subject to final approval from the TSX Venture Exchange.



The completion of the sale transaction is a significant milestone for Earth Alive Clean Technologies Inc. As the Company moves forward with its new shareholder and management structure, it is well-positioned to capitalize on the growing demand for innovative, environmentally sound, and proprietary microbial solutions in various industries, including agriculture, mining, and industrial cleaning. With a robust pipeline of projects for 2023 and a strong commitment to research and development, Earth Alive is poised to continue its growth trajectory and create value for its shareholders.

Investors should closely monitor Earth Alive's progress and consider the potential opportunities that the completion of the sale transaction presents. As the Company continues to execute on its strategic initiatives and expand its market reach, it may offer an attractive investment opportunity in the microbial technologies industry.